Comparison of Two Pediatric-Inspired Regimens to Hyper-CVAD in Hispanic Adolescents and Young Adults With Acute Lymphoblastic Leukemia
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 21 (1) , 55-62.e2
Abstract
No abstract availableKeywords
Funding Information
- Instituto Nacional de Cancerología
This publication has 39 references indexed in Scilit:
- The Tumor Lysis SyndromeNew England Journal of Medicine, 2011
- Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcomeBlood, 2010
- Outcome of adults with acute lymphoblastic leukemia treated with a pediatric-inspired therapy: a single institution experienceLeukemia & Lymphoma, 2010
- Chemoimmunotherapy With a Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome–Negative Precursor B-Lineage Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2010
- Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemiaBlood, 2010
- What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studiesBlood, 2008
- Acute lymphoblastic leukemia in adolescents and young adults in FinlandHaematologica, 2008
- Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard-Risk Acute Lymphoblastic Leukemia With the Programa Español de Tratamiento en Hematología Pediatric-Based Protocol ALL-96Journal of Clinical Oncology, 2008
- Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in SwedenCancer, 2006
- Adolescents with acute lymphoblastic leukaemia: Emerging from the shadow of paediatric and adult treatment protocolsPediatric Blood & Cancer, 2006